Form 4: Columbia Financial CEO Thomas J. Kemly Reports Stock Transactions
SEC Form 4 Filing
Columbia Financial's CEO, Thomas J. Kemly, reported the acquisition of phantom stock and details of his holdings in company stock and options.
Summary
- Thomas J. Kemly, CEO of Columbia Financial, Inc., reported a transaction on November 29, 2024, involving the acquisition of 113.9292 shares of phantom stock at a price of $18.23 per share through the company's Stock-Based Deferral Plan.
- Following this transaction, Mr. Kemly's total holdings include 224,860 shares of common stock held directly, and various indirect holdings through a 401(k), ESOP, SERP, SIM, spouse, and stock awards.
- Mr. Kemly also holds stock options, including 656,471 options exercisable at $15.60, 37,894 options at $15.94, and 37,168 options at $16.49.
- The stock options have various vesting schedules, with some fully vested and others vesting in installments.
Sentiment
Score: 7
Explanation: The document is a routine disclosure of insider transactions, which is generally neutral. The CEO's participation in company plans and significant holdings are positive indicators.
Positives
- The acquisition of phantom stock through the Stock-Based Deferral Plan indicates continued participation in company incentive programs.
- The CEO's significant holdings of common stock and stock options align his interests with those of shareholders.
Industry Context
This filing is a routine disclosure of insider transactions, which is common for publicly traded companies. It provides transparency into the holdings of key executives.
Comparison to Industry Standards
- The vesting schedules for stock options and awards are typical for executive compensation packages in the financial services industry.
- The use of stock-based deferral plans and various retirement accounts for stock holdings is a common practice among publicly traded companies.
- The number of stock options and shares held by the CEO is within the expected range for a company of Columbia Financial's size and market capitalization.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the CEO's holdings and alignment of interests.
- The transactions do not have a direct impact on employees, customers, or suppliers.
Key Dates
| Date | Description |
|---|---|
| 07/23/2020 | Grant date of stock options exercisable at $15.60. |
| 05/01/2024 | Commencement of vesting for some stock awards and stock options. |
| 11/29/2024 | Date of phantom stock acquisition. |
| 03/06/2025 | Commencement of vesting for some stock awards and stock options. |
| 07/23/2029 | Expiration date of stock options exercisable at $15.60. |
| 05/01/2033 | Expiration date of stock options exercisable at $15.94. |
| 03/06/2034 | Expiration date of stock options exercisable at $16.49. |
| 12/03/2024 | Date of filing of the Form 4. |
Keywords
stock options, stock awards, phantom stock, insider trading, beneficial ownership, equity incentive plan, stock-based deferral plan, Columbia Financial, CLBK, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.